CCN1
Basic information
Region (hg38): 1:85580761-85584589
Previous symbols: [ "IGFBP10", "CYR61" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 13 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 13 | 1 | 4 |
Variants in CCN1
This is a list of pathogenic ClinVar variants found in the CCN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-85580878-C-A | Benign (Nov 11, 2018) | |||
1-85581000-G-T | not specified | Uncertain significance (Nov 15, 2021) | ||
1-85581033-C-T | not specified | Uncertain significance (Apr 04, 2023) | ||
1-85581241-G-A | Benign (Nov 11, 2018) | |||
1-85581377-T-G | not specified | Uncertain significance (Nov 08, 2022) | ||
1-85581408-C-T | not specified | Uncertain significance (Aug 15, 2023) | ||
1-85581431-G-T | not specified | Uncertain significance (Apr 20, 2024) | ||
1-85581464-G-T | not specified | Uncertain significance (Sep 20, 2023) | ||
1-85581628-G-C | Benign (Nov 12, 2018) | |||
1-85582167-G-C | not specified | Uncertain significance (Feb 17, 2024) | ||
1-85582439-C-G | not specified | Uncertain significance (Dec 16, 2022) | ||
1-85582535-A-G | not specified | Uncertain significance (Jul 11, 2023) | ||
1-85582538-A-G | not specified | Uncertain significance (Jul 30, 2023) | ||
1-85582774-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
1-85582787-G-C | not specified | Uncertain significance (Apr 06, 2023) | ||
1-85582796-C-T | Benign (May 03, 2018) | |||
1-85582840-G-A | not specified | Uncertain significance (May 23, 2023) | ||
1-85582842-T-G | not specified | Uncertain significance (Jan 10, 2023) | ||
1-85582843-C-G | Likely benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCN1 | protein_coding | protein_coding | ENST00000451137 | 5 | 3202 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.714 | 0.286 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.366 | 201 | 216 | 0.930 | 0.0000119 | 2474 |
Missense in Polyphen | 77 | 95.93 | 0.80267 | 1133 | ||
Synonymous | 0.499 | 84 | 90.0 | 0.933 | 0.00000527 | 729 |
Loss of Function | 3.18 | 3 | 17.2 | 0.174 | 8.99e-7 | 203 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000951 | 0.0000924 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Promotes cell proliferation, chemotaxis, angiogenesis and cell adhesion. Appears to play a role in wound healing by up- regulating, in skin fibroblasts, the expression of a number of genes involved in angiogenesis, inflammation and matrix remodeling including VEGA-A, VEGA-C, MMP1, MMP3, TIMP1, uPA, PAI-1 and integrins alpha-3 and alpha-5. CYR61-mediated gene regulation is dependent on heparin-binding. Down-regulates the expression of alpha-1 and alpha-2 subunits of collagen type-1. Promotes cell adhesion and adhesive signaling through integrin alpha-6/beta-1, cell migration through integrin alpha-v/beta-5 and cell proliferation through integrin alpha-v/beta-3. {ECO:0000269|PubMed:11584015}.;
Recessive Scores
- pRec
- 0.787
Intolerance Scores
- loftool
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 45.13
Haploinsufficiency Scores
- pHI
- 0.535
- hipred
- Y
- hipred_score
- 0.853
- ghis
- 0.554
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Ccn1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; embryo phenotype; liver/biliary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);